aluates Reports

$ 0.0

Automative

Global Engineered Cell Therapy Market Research Report 2024

Published Date: September 2024

Report Code: QYRE-Auto-3Y14505

Global Engineered Cell Therapy Market Research Report 2023

BUY CHAPTERS

Global Engineered Cell Therapy Market Research Report 2024

Code: QYRE-Auto-3Y14505

Report

September 2024

Pages:103

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Engineered Cell Therapy Market Size

The global Engineered Cell Therapy market was valued at US$ 4230 million in 2023 and is anticipated to reach US$ 10580 million by 2030, witnessing a CAGR of 14.0% during the forecast period 2024-2030.

Engineered Cell Therapy Market

Engineered cell therapy is designed to improve the ability of a patient's immune system to fight cancer by reintroducing improved immune cells. They are manufactured by collecting specific immune cells, called T cells, from the blood of the patient.

North American market for Engineered Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Engineered Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Engineered Cell Therapy in Research Institutes is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Engineered Cell Therapy include Medtronic, Stryker, Zimmer Inc., Acelity, Allergan, Cook Medical, Baxter International, Organovo Holdings Inc and Integra LifeSciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Engineered Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Engineered Cell Therapy.

Report Scope

The Engineered Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Engineered Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Engineered Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Engineered Cell Therapy Market Report

Report Metric	Details
Report Name	Engineered Cell Therapy Market
Accounted market size in 2023	US$ 4230 million
Forecasted market size in 2030	US$ 10580 million
CAGR	14.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Synthetic Biologically Derived Others
Segment by Application	Research Institutes Biotechnological Organizations Diagnostic Centres
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Medtronic, Stryker, Zimmer Inc., Acelity, Allergan, Cook Medical, Baxter International, Organovo Holdings Inc, Integra LifeSciences, DePuy Synthes, B. Braun Melsungen AG, AbbVie, Becton, Dickinson and Company, Organogenesis Inc., Athersys Inc., ReproCell Inc., RTI Surgical Inc., Tissue Regenix Group Plc, RepliCel.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Engineered Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Engineered Cell Therapy Market growing?

Ans: The Engineered Cell Therapy Market witnessing a CAGR of 14.0% during the forecast period 2024-2030.

What is the Engineered Cell Therapy Market size in 2030?

Ans: The Engineered Cell Therapy Market size in 2030 will be US$ 10580 million.

Who are the main players in the Engineered Cell Therapy Market report?

Ans: The main players in the Engineered Cell Therapy Market are Medtronic, Stryker, Zimmer Inc., Acelity, Allergan, Cook Medical, Baxter International, Organovo Holdings Inc, Integra LifeSciences, DePuy Synthes, B. Braun Melsungen AG, AbbVie, Becton, Dickinson and Company, Organogenesis Inc., Athersys Inc., ReproCell Inc., RTI Surgical Inc., Tissue Regenix Group Plc, RepliCel.

What are the Application segmentation covered in the Engineered Cell Therapy Market report?

Ans: The Applications covered in the Engineered Cell Therapy Market report are Research Institutes, Biotechnological Organizations, Diagnostic Centres

What are the Type segmentation covered in the Engineered Cell Therapy Market report?

Ans: The Types covered in the Engineered Cell Therapy Market report are Synthetic, Biologically Derived, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Engineered Cell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Synthetic

1.2.3 Biologically Derived

1.2.4 Others

1.3 Market by Application

1.3.1 Global Engineered Cell Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Research Institutes

1.3.3 Biotechnological Organizations

1.3.4 Diagnostic Centres

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Engineered Cell Therapy Market Perspective (2019-2030)

2.2 Engineered Cell Therapy Growth Trends by Region

2.2.1 Global Engineered Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Engineered Cell Therapy Historic Market Size by Region (2019-2024)

2.2.3 Engineered Cell Therapy Forecasted Market Size by Region (2025-2030)

2.3 Engineered Cell Therapy Market Dynamics

2.3.1 Engineered Cell Therapy Industry Trends

2.3.2 Engineered Cell Therapy Market Drivers

2.3.3 Engineered Cell Therapy Market Challenges

2.3.4 Engineered Cell Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Engineered Cell Therapy Players by Revenue

3.1.1 Global Top Engineered Cell Therapy Players by Revenue (2019-2024)

3.1.2 Global Engineered Cell Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Engineered Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Engineered Cell Therapy Revenue

3.4 Global Engineered Cell Therapy Market Concentration Ratio

3.4.1 Global Engineered Cell Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Engineered Cell Therapy Revenue in 2023

3.5 Engineered Cell Therapy Key Players Head office and Area Served

3.6 Key Players Engineered Cell Therapy Product Solution and Service

3.7 Date of Enter into Engineered Cell Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Engineered Cell Therapy Breakdown Data by Type

4.1 Global Engineered Cell Therapy Historic Market Size by Type (2019-2024)

4.2 Global Engineered Cell Therapy Forecasted Market Size by Type (2025-2030)

5 Engineered Cell Therapy Breakdown Data by Application

5.1 Global Engineered Cell Therapy Historic Market Size by Application (2019-2024)

5.2 Global Engineered Cell Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Engineered Cell Therapy Market Size (2019-2030)

6.2 North America Engineered Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Engineered Cell Therapy Market Size by Country (2019-2024)

6.4 North America Engineered Cell Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Engineered Cell Therapy Market Size (2019-2030)

7.2 Europe Engineered Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Engineered Cell Therapy Market Size by Country (2019-2024)

7.4 Europe Engineered Cell Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Engineered Cell Therapy Market Size (2019-2030)

8.2 Asia-Pacific Engineered Cell Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Engineered Cell Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Engineered Cell Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Engineered Cell Therapy Market Size (2019-2030)

9.2 Latin America Engineered Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Engineered Cell Therapy Market Size by Country (2019-2024)

9.4 Latin America Engineered Cell Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Engineered Cell Therapy Market Size (2019-2030)

10.2 Middle East & Africa Engineered Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Engineered Cell Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Engineered Cell Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Medtronic

11.1.1 Medtronic Company Detail

11.1.2 Medtronic Business Overview

11.1.3 Medtronic Engineered Cell Therapy Introduction

11.1.4 Medtronic Revenue in Engineered Cell Therapy Business (2019-2024)

11.1.5 Medtronic Recent Development

11.2 Stryker

11.2.1 Stryker Company Detail

11.2.2 Stryker Business Overview

11.2.3 Stryker Engineered Cell Therapy Introduction

11.2.4 Stryker Revenue in Engineered Cell Therapy Business (2019-2024)

11.2.5 Stryker Recent Development

11.3 Zimmer Inc.

11.3.1 Zimmer Inc. Company Detail

11.3.2 Zimmer Inc. Business Overview

11.3.3 Zimmer Inc. Engineered Cell Therapy Introduction

11.3.4 Zimmer Inc. Revenue in Engineered Cell Therapy Business (2019-2024)

11.3.5 Zimmer Inc. Recent Development

11.4 Acelity

11.4.1 Acelity Company Detail

11.4.2 Acelity Business Overview

11.4.3 Acelity Engineered Cell Therapy Introduction

11.4.4 Acelity Revenue in Engineered Cell Therapy Business (2019-2024)

11.4.5 Acelity Recent Development

11.5 Allergan

11.5.1 Allergan Company Detail

11.5.2 Allergan Business Overview

11.5.3 Allergan Engineered Cell Therapy Introduction

11.5.4 Allergan Revenue in Engineered Cell Therapy Business (2019-2024)

11.5.5 Allergan Recent Development

11.6 Cook Medical

11.6.1 Cook Medical Company Detail

11.6.2 Cook Medical Business Overview

11.6.3 Cook Medical Engineered Cell Therapy Introduction

11.6.4 Cook Medical Revenue in Engineered Cell Therapy Business (2019-2024)

11.6.5 Cook Medical Recent Development

11.7 Baxter International

11.7.1 Baxter International Company Detail

11.7.2 Baxter International Business Overview

11.7.3 Baxter International Engineered Cell Therapy Introduction

11.7.4 Baxter International Revenue in Engineered Cell Therapy Business (2019-2024)

11.7.5 Baxter International Recent Development

11.8 Organovo Holdings Inc

11.8.1 Organovo Holdings Inc Company Detail

11.8.2 Organovo Holdings Inc Business Overview

11.8.3 Organovo Holdings Inc Engineered Cell Therapy Introduction

11.8.4 Organovo Holdings Inc Revenue in Engineered Cell Therapy Business (2019-2024)

11.8.5 Organovo Holdings Inc Recent Development

11.9 Integra LifeSciences

11.9.1 Integra LifeSciences Company Detail

11.9.2 Integra LifeSciences Business Overview

11.9.3 Integra LifeSciences Engineered Cell Therapy Introduction

11.9.4 Integra LifeSciences Revenue in Engineered Cell Therapy Business (2019-2024)

11.9.5 Integra LifeSciences Recent Development

11.10 DePuy Synthes

11.10.1 DePuy Synthes Company Detail

11.10.2 DePuy Synthes Business Overview

11.10.3 DePuy Synthes Engineered Cell Therapy Introduction

11.10.4 DePuy Synthes Revenue in Engineered Cell Therapy Business (2019-2024)

11.10.5 DePuy Synthes Recent Development

11.11 B. Braun Melsungen AG

11.11.1 B. Braun Melsungen AG Company Detail

11.11.2 B. Braun Melsungen AG Business Overview

11.11.3 B. Braun Melsungen AG Engineered Cell Therapy Introduction

11.11.4 B. Braun Melsungen AG Revenue in Engineered Cell Therapy Business (2019-2024)

11.11.5 B. Braun Melsungen AG Recent Development

11.12 AbbVie

11.12.1 AbbVie Company Detail

11.12.2 AbbVie Business Overview

11.12.3 AbbVie Engineered Cell Therapy Introduction

11.12.4 AbbVie Revenue in Engineered Cell Therapy Business (2019-2024)

11.12.5 AbbVie Recent Development

11.13 Becton

11.13.1 Becton Company Detail

11.13.2 Becton Business Overview

11.13.3 Becton Engineered Cell Therapy Introduction

11.13.4 Becton Revenue in Engineered Cell Therapy Business (2019-2024)

11.13.5 Becton Recent Development

11.14 Dickinson and Company

11.14.1 Dickinson and Company Company Detail

11.14.2 Dickinson and Company Business Overview

11.14.3 Dickinson and Company Engineered Cell Therapy Introduction

11.14.4 Dickinson and Company Revenue in Engineered Cell Therapy Business (2019-2024)

11.14.5 Dickinson and Company Recent Development

11.15 Organogenesis Inc.

11.15.1 Organogenesis Inc. Company Detail

11.15.2 Organogenesis Inc. Business Overview

11.15.3 Organogenesis Inc. Engineered Cell Therapy Introduction

11.15.4 Organogenesis Inc. Revenue in Engineered Cell Therapy Business (2019-2024)

11.15.5 Organogenesis Inc. Recent Development

11.16 Athersys Inc.

11.16.1 Athersys Inc. Company Detail

11.16.2 Athersys Inc. Business Overview

11.16.3 Athersys Inc. Engineered Cell Therapy Introduction

11.16.4 Athersys Inc. Revenue in Engineered Cell Therapy Business (2019-2024)

11.16.5 Athersys Inc. Recent Development

11.17 ReproCell Inc.

11.17.1 ReproCell Inc. Company Detail

11.17.2 ReproCell Inc. Business Overview

11.17.3 ReproCell Inc. Engineered Cell Therapy Introduction

11.17.4 ReproCell Inc. Revenue in Engineered Cell Therapy Business (2019-2024)

11.17.5 ReproCell Inc. Recent Development

11.18 RTI Surgical Inc.

11.18.1 RTI Surgical Inc. Company Detail

11.18.2 RTI Surgical Inc. Business Overview

11.18.3 RTI Surgical Inc. Engineered Cell Therapy Introduction

11.18.4 RTI Surgical Inc. Revenue in Engineered Cell Therapy Business (2019-2024)

11.18.5 RTI Surgical Inc. Recent Development

11.19 Tissue Regenix Group Plc

11.19.1 Tissue Regenix Group Plc Company Detail

11.19.2 Tissue Regenix Group Plc Business Overview

11.19.3 Tissue Regenix Group Plc Engineered Cell Therapy Introduction

11.19.4 Tissue Regenix Group Plc Revenue in Engineered Cell Therapy Business (2019-2024)

11.19.5 Tissue Regenix Group Plc Recent Development

11.20 RepliCel.

11.20.1 RepliCel. Company Detail

11.20.2 RepliCel. Business Overview

11.20.3 RepliCel. Engineered Cell Therapy Introduction

11.20.4 RepliCel. Revenue in Engineered Cell Therapy Business (2019-2024)

11.20.5 RepliCel. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Engineered Cell Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Synthetic

Table 3. Key Players of Biologically Derived

Table 4. Key Players of Others

Table 5. Global Engineered Cell Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Engineered Cell Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Engineered Cell Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Engineered Cell Therapy Market Share by Region (2019-2024)

Table 9. Global Engineered Cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Engineered Cell Therapy Market Share by Region (2025-2030)

Table 11. Engineered Cell Therapy Market Trends

Table 12. Engineered Cell Therapy Market Drivers

Table 13. Engineered Cell Therapy Market Challenges

Table 14. Engineered Cell Therapy Market Restraints

Table 15. Global Engineered Cell Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Engineered Cell Therapy Market Share by Players (2019-2024)

Table 17. Global Top Engineered Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Engineered Cell Therapy as of 2023)

Table 18. Ranking of Global Top Engineered Cell Therapy Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Engineered Cell Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Engineered Cell Therapy Product Solution and Service

Table 22. Date of Enter into Engineered Cell Therapy Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Engineered Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Engineered Cell Therapy Revenue Market Share by Type (2019-2024)

Table 26. Global Engineered Cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Engineered Cell Therapy Revenue Market Share by Type (2025-2030)

Table 28. Global Engineered Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Engineered Cell Therapy Revenue Market Share by Application (2019-2024)

Table 30. Global Engineered Cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Engineered Cell Therapy Revenue Market Share by Application (2025-2030)

Table 32. North America Engineered Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Engineered Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Engineered Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Engineered Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Engineered Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Engineered Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Engineered Cell Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Engineered Cell Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Engineered Cell Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Engineered Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Engineered Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Engineered Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Engineered Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Engineered Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Engineered Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 47. Medtronic Company Detail

Table 48. Medtronic Business Overview

Table 49. Medtronic Engineered Cell Therapy Product

Table 50. Medtronic Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 51. Medtronic Recent Development

Table 52. Stryker Company Detail

Table 53. Stryker Business Overview

Table 54. Stryker Engineered Cell Therapy Product

Table 55. Stryker Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 56. Stryker Recent Development

Table 57. Zimmer Inc. Company Detail

Table 58. Zimmer Inc. Business Overview

Table 59. Zimmer Inc. Engineered Cell Therapy Product

Table 60. Zimmer Inc. Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 61. Zimmer Inc. Recent Development

Table 62. Acelity Company Detail

Table 63. Acelity Business Overview

Table 64. Acelity Engineered Cell Therapy Product

Table 65. Acelity Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 66. Acelity Recent Development

Table 67. Allergan Company Detail

Table 68. Allergan Business Overview

Table 69. Allergan Engineered Cell Therapy Product

Table 70. Allergan Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 71. Allergan Recent Development

Table 72. Cook Medical Company Detail

Table 73. Cook Medical Business Overview

Table 74. Cook Medical Engineered Cell Therapy Product

Table 75. Cook Medical Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 76. Cook Medical Recent Development

Table 77. Baxter International Company Detail

Table 78. Baxter International Business Overview

Table 79. Baxter International Engineered Cell Therapy Product

Table 80. Baxter International Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 81. Baxter International Recent Development

Table 82. Organovo Holdings Inc Company Detail

Table 83. Organovo Holdings Inc Business Overview

Table 84. Organovo Holdings Inc Engineered Cell Therapy Product

Table 85. Organovo Holdings Inc Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 86. Organovo Holdings Inc Recent Development

Table 87. Integra LifeSciences Company Detail

Table 88. Integra LifeSciences Business Overview

Table 89. Integra LifeSciences Engineered Cell Therapy Product

Table 90. Integra LifeSciences Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 91. Integra LifeSciences Recent Development

Table 92. DePuy Synthes Company Detail

Table 93. DePuy Synthes Business Overview

Table 94. DePuy Synthes Engineered Cell Therapy Product

Table 95. DePuy Synthes Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 96. DePuy Synthes Recent Development

Table 97. B. Braun Melsungen AG Company Detail

Table 98. B. Braun Melsungen AG Business Overview

Table 99. B. Braun Melsungen AG Engineered Cell Therapy Product

Table 100. B. Braun Melsungen AG Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 101. B. Braun Melsungen AG Recent Development

Table 102. AbbVie Company Detail

Table 103. AbbVie Business Overview

Table 104. AbbVie Engineered Cell Therapy Product

Table 105. AbbVie Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 106. AbbVie Recent Development

Table 107. Becton Company Detail

Table 108. Becton Business Overview

Table 109. Becton Engineered Cell Therapy Product

Table 110. Becton Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 111. Becton Recent Development

Table 112. Dickinson and Company Company Detail

Table 113. Dickinson and Company Business Overview

Table 114. Dickinson and Company Engineered Cell Therapy Product

Table 115. Dickinson and Company Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 116. Dickinson and Company Recent Development

Table 117. Organogenesis Inc. Company Detail

Table 118. Organogenesis Inc. Business Overview

Table 119. Organogenesis Inc. Engineered Cell Therapy Product

Table 120. Organogenesis Inc. Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 121. Organogenesis Inc. Recent Development

Table 122. Athersys Inc. Company Detail

Table 123. Athersys Inc. Business Overview

Table 124. Athersys Inc. Engineered Cell Therapy Product

Table 125. Athersys Inc. Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 126. Athersys Inc. Recent Development

Table 127. ReproCell Inc. Company Detail

Table 128. ReproCell Inc. Business Overview

Table 129. ReproCell Inc. Engineered Cell Therapy Product

Table 130. ReproCell Inc. Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 131. ReproCell Inc. Recent Development

Table 132. RTI Surgical Inc. Company Detail

Table 133. RTI Surgical Inc. Business Overview

Table 134. RTI Surgical Inc. Engineered Cell Therapy Product

Table 135. RTI Surgical Inc. Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 136. RTI Surgical Inc. Recent Development

Table 137. Tissue Regenix Group Plc Company Detail

Table 138. Tissue Regenix Group Plc Business Overview

Table 139. Tissue Regenix Group Plc Engineered Cell Therapy Product

Table 140. Tissue Regenix Group Plc Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 141. Tissue Regenix Group Plc Recent Development

Table 142. RepliCel. Company Detail

Table 143. RepliCel. Business Overview

Table 144. RepliCel. Engineered Cell Therapy Product

Table 145. RepliCel. Revenue in Engineered Cell Therapy Business (2019-2024) & (US$ Million)

Table 146. RepliCel. Recent Development

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Engineered Cell Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Engineered Cell Therapy Market Share by Type: 2023 VS 2030

Figure 3. Synthetic Features

Figure 4. Biologically Derived Features

Figure 5. Others Features

Figure 6. Global Engineered Cell Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Engineered Cell Therapy Market Share by Application: 2023 VS 2030

Figure 8. Research Institutes Case Studies

Figure 9. Biotechnological Organizations Case Studies

Figure 10. Diagnostic Centres Case Studies

Figure 11. Engineered Cell Therapy Report Years Considered

Figure 12. Global Engineered Cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Engineered Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Engineered Cell Therapy Market Share by Region: 2023 VS 2030

Figure 15. Global Engineered Cell Therapy Market Share by Players in 2023

Figure 16. Global Top Engineered Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Engineered Cell Therapy as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Engineered Cell Therapy Revenue in 2023

Figure 18. North America Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Engineered Cell Therapy Market Share by Country (2019-2030)

Figure 20. United States Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Engineered Cell Therapy Market Share by Country (2019-2030)

Figure 24. Germany Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Engineered Cell Therapy Market Share by Region (2019-2030)

Figure 32. China Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Engineered Cell Therapy Market Share by Country (2019-2030)

Figure 40. Mexico Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Engineered Cell Therapy Market Share by Country (2019-2030)

Figure 44. Turkey Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Engineered Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Medtronic Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 47. Stryker Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 48. Zimmer Inc. Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 49. Acelity Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 50. Allergan Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 51. Cook Medical Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 52. Baxter International Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 53. Organovo Holdings Inc Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 54. Integra LifeSciences Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 55. DePuy Synthes Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 56. B. Braun Melsungen AG Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 57. AbbVie Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 58. Becton Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 59. Dickinson and Company Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 60. Organogenesis Inc. Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 61. Athersys Inc. Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 62. ReproCell Inc. Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 63. RTI Surgical Inc. Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 64. Tissue Regenix Group Plc Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 65. RepliCel. Revenue Growth Rate in Engineered Cell Therapy Business (2019-2024)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-6F14203

Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Sterile Hospital Laundry System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-5G12958

Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Hospital Isolation Enclosure - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-31Z12796

Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Orthopedic Therapeutic Hyaluronic Acid End Products - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-8Y14082

Wed Nov 06 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Engineered Cell Therapy Market Research Report 2024

Published Date: September 2024

Report Code: QYRE-Auto-3Y14505

Global Engineered Cell Therapy Market Research Report 2024

FEATURED COMPANIES

Engineered Cell Therapy Market Size

Engineered Cell Therapy Market

Report Scope

Scope of Engineered Cell Therapy Market Report

Chapter Outline

FAQ for this report

How fast is Engineered Cell Therapy Market growing?

What is the Engineered Cell Therapy Market size in 2030?

Who are the main players in the Engineered Cell Therapy Market report?

What are the Application segmentation covered in the Engineered Cell Therapy Market report?

What are the Type segmentation covered in the Engineered Cell Therapy Market report?

FEATURED COMPANIES

RELATED REPORTS